Piramal Pharma Solutions, a leading global Contract Development and Manufacturing Organization (CDMO) and part of Piramal Pharma Ltd. (NSE: PPLPHARMA) (BSE: 543635), is proud to announce the ...

Elisabeth Schweiberer, one of the first graduates of the Master’s program Pharmaceutical Sciences – Drug Development and ...

Kivo reports that the journey of prescription drugs involves extensive research, clinical trials, regulatory reviews, and ...

Adamawa State Governor, Ahmadu Fintiri, is set to host the Pharmaceutical Society of Nigeria (PSN) Colloquium in Yola from March 29 to April 1, 2026, at the banquet hall of the government house in ...

At the end of January 2026, AstraZeneca, a Swedish-British pharmaceutical and biotechnology company, announced its re-entry into China's pharmaceutical market with a $15 billion investment over the ...

Funding and clinical trial-based barriers must be addressed to ensure success on the path to developing DMTs for Parkinson’s disease.

Irish Pharmaceutical Healthcare Association president Shane Ryan is confident a new accord with Government can deliver for ...

Scientists at the University of Cambridge have developed a new way to alter complex drug molecules using light rather than toxic chemicals – a discovery that could accelerate and improve how medicines ...

Drug discovery has traditionally been a reductive process—narrowing down, filtering out, and optimizing within established constraints. Generative AI turns that on its head. It is an expansive force, ...

It takes a long time, many different steps, and considerable cost, before a new drug can be approved for use as a medicine. One could be forgiven for thinking that, since billions of people across the ...

A surprising lab discovery reveals a light-powered way to tweak complex drugs faster, cleaner, and later in development.